Zobrazeno 1 - 10
of 405
pro vyhledávání: '"Donna E. Reece"'
Autor:
Richard Leblanc, Christopher P. Venner, Esther Masih-Khan, Moustafa Kardjadj, Michael P. Chu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Kevin Song, Michael Sebag, Martha L Louzada, Hira S Mian, Darrell J White, Julie Stakiw, Rami Kotb, Anthony Reiman, Muhammad Aslam, Rayan Kaedbey, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:7192-7194
Autor:
Julie Cote, Richard Leblanc, Michael P. Chu, Arleigh McCurdy, Esther Masih-Khan, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Kevin Song, Martha L Louzada, Hira S Mian, Darrell White, Michael Sebag, Anthony Reiman, Julie Stakiw, Rami Kotb, Debra Bergstrom, Muhammad Aslam, Rayan Kaedbey, Christopher P. Venner, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:289-291
Autor:
Alissa Visram, Alfredo De La Torre, Darrell White, Moustafa Kardjadj, Esther Masih-Khan, Michael P. Chu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Richard Leblanc, Kevin Song, Hira S Mian, Martha L Louzada, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Christopher P. Venner, Rayan Kaedbey, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:4287-4289
Autor:
Vishal Kukreti, Eshetu G. Atenafu, Anca Prica, Michael Crump, Alfredo De la Torre, Christine Chen, Donna E. Reece
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e946-e959
Introduction Light chain (AL) amyloidosis and B‐cell lymphoma represent 5% to 7% of all AL, Systemic amyloidosis, deposits in sites remote from the underlying lymphoma, and peritumoral amyloidosis deposition is within the immediate vicinity. Materi
Autor:
Donna E. Reece, Anca Prica, Christine Chen, Esther Masih-Khan, Alfonso Rivera Duarte, Harminder Paul, Suzanne Trudel, Rodger E. Tiedemann, Vishal Kukreti, Andrew Winter, Xuan Li, Wei Xu
Publikováno v:
Amyloid. 29:23-30
The main objective of treatment in systemic light chain amyloidosis (AL amyloidosis) is to achieve the best hematological response. Deeper responses are associated with better organ responses and s...
Autor:
Suzanne Trudel, Eshetu G. Atenafu, Chenyu Yao, Mariya S. Liyasova, Donna E. Reece, Qixin Liu, Bin Ma, Zac McDonald, Xin Xu, Giovanni Piza, Kathleen Gorospe, Paul J. Taylor, Liqiang Yang
Publikováno v:
Clinical Cancer Research. 27:5028-5037
Purpose: M-protein is a well-established biomarker used for multiple myeloma monitoring. Current improvements in multiple myeloma treatment created the need to monitor minimal residual disease (MRD) with high sensitivity. Measuring residual levels of
Autor:
Bingshu E. Chen, Lois E. Shepherd, Harriet Richardson, Donna E. Reece, Christopher P. Venner, Bethany Monteith, Joe Pater, Rodger E. Tiedemann, Vishal Kukreti, Matthew C. Cheung, Jill Dudebout, Hope Yen, Marc Lalancette, Chai Phua, Max Sherry, Annette E. Hay, Engin Gul, Vincent Castonguay, Sita D. Bhella
Publikováno v:
European Journal of Haematology. 107:333-342
Background The prevalence of multiple myeloma is increasing and there is a need to evaluate escalating therapy costs (Canadian Cancer Statistics A, 2020). The MYX.1 phase II trial showed that high-dose weekly carfilzomib, cyclophosphamide, and dexame
Autor:
Suzanne Trudel, Arleigh McCurdy, Molei Fu, Heather J. Sutherland, Martha L Louzada, Michael P. Chu, Darrell J White, Hira S Mian, Rami Kotb, Ibraheem Othman, Moustafa Kardjadj, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:7306-7307
Autor:
Christopher P. Venner, Donna E. Reece, Steven Baker, Vera Bril, Diego Delgado, Mervyn Carr, Geneviève Giraldeau, Victoria Hodgkinson, Victor H Jimenez-Zepeda, Liam A. Laidlaw, Rami Massie, Marsha McWhinnie, Ian Paterson, Nowell Fine, Margot Davis
Publikováno v:
Blood. 140:13162-13163
Autor:
Anup Joseph Devasia, Sahar Khan, Harminder K Paul, Frédéric Larose, Eshetu G. Atenafu, Donna E. Reece, Suzanne Trudel, A. Keith Stewart, Sita Bhella, Vishal Kukreti, Chloe Yang, Rodger E Tiedemann, Anca Prica, Monica Monchis, Eugene Leung, Susan Jomah, Zubaida Mohamed, Christine Chen
Publikováno v:
Blood. 140:10043-10044